Chemotherapy Infusion Pumps Market Report 2024

This Chemotherapy Infusion Pumps industry report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The chemotherapy infusion pump market size has grown strongly in recent years. It will grow from $4.64 billion in 2023 to $4.92 billion in 2024 at a compound annual growth rate (CAGR) of 6.1%. The growth during the historic period can be attributed to factors such as the shift towards outpatient care, increasing cancer incidence, advancements in healthcare infrastructure, an aging population, and rising healthcare expenditure.

The chemotherapy infusion pump market size is expected to see strong growth in the next few years. It will grow to $6.26 billion in 2028 at a compound annual growth rate (CAGR) of 6.2%. The projected growth during the forecast period can be attributed to the expansion of home healthcare services, rising cancer incidence, increased awareness and screening programs, favorable regulatory policies, and expedited approval processes for new medical devices. Major trends expected to influence the market include the integration of smart technologies, the rise of home-based chemotherapy treatments, a focus on infusion pumps with advanced safety features, the development of customized and precision infusion pumps, and improved integration with electronic health records (EHR) systems.

The rising incidence of cancer is expected to drive the growth of the chemotherapy infusion pumps market. Cancer is a group of diseases marked by uncontrolled cell growth and spread within the body, influenced by factors such as lifestyle changes, genetic predispositions, and environmental elements such as smoking, radiation, chemicals, and infections. Chemotherapy infusion pumps support cancer patients by providing accurate, continuous doses of chemotherapy drugs, improving drug administration, and reducing side effects. For example, in February 2024, the World Health Organization, based in Switzerland, projected over 35 million new cancer cases by 2050, up 77% from the 20 million cases estimated for 2022. This rising incidence of cancer is set to boost the demand for chemotherapy infusion pumps.

Key players in the chemotherapy infusion pumps market are developing advanced technologies, such as customizable infusion rates for multiple chemotherapy drugs, to offer more personalized and precise treatment options. Customizable infusion rates enable healthcare providers to adjust the delivery speed and dosage of chemotherapy drugs according to individual patient needs. For instance, in May 2023, Mindray, a medical device and solution provider from China, launched a new infusion mode called 'Rhythm Dose' in their BeneFusion i/u infusion pump series. This feature is designed to optimize chemotherapy drug delivery, allowing continuous intravenous infusions of multiple drugs at varying rates for more personalized treatment plans.

In June 2022, Delta Med GmbH, a Germany-based company specializing in intravenous therapy solutions, acquired Adria Med for an undisclosed amount. This acquisition aims to broaden Delta Med's product range and strengthen its presence in the medical device sector. It enhances Delta Med's capabilities in intravenous therapy and extends its reach to a wider customer base. Adria Med, based in Croatia, focuses on infusion therapy medical devices and solutions, including chemotherapy infusion pumps, with an emphasis on advanced intravenous treatment products.

Major companies operating in the chemotherapy infusion pumps market are Johnson & Johnson Services Inc., Medtronic plc, Becton Dickinson and Company, Baxter International Inc., Medline Industries LP, B. Braun Holding GmbH & Co. KG, Fresenius Kabi AG, Grifols S.A., Terumo Corporation, Nipro Corporation, Smiths Group plc, Moog Inc., Avanos Medical Inc., Halyard Health, Vygon SAS, Palex Medical SA, Samtronic SA, ICU Medical Inc., Pfm Medical Ag, Zyno Medical LLC, Leventon S.A.U., InfuTronix Solutions LLC, Heka Healthcare, PROMECON GmbH.

North America was the largest region in the chemotherapy infusion pump market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chemotherapy infusion pumps market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the chemotherapy infusion pumps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Chemotherapy infusion pumps are specialized medical devices used to deliver precise and continuous doses of chemotherapy drugs to cancer patients. They play a crucial role in optimizing drug administration, minimizing side effects, and enabling treatments to be administered over extended periods, whether in a hospital setting or at home.

The primary types of chemotherapy infusion pumps in the market include large volume pumps, syringe pumps, elastomeric pumps, ambulatory infusion pumps, and others. Large volume chemotherapy infusion pumps are designed to administer significant quantities of chemotherapy drugs over extended durations. These pumps can be either disposable or reusable and are utilized by various end users, including hospitals, clinics, home care settings, and other medical environments.

The chemotherapy infusion pumps market research report is one of a series of new reports that provides chemotherapy infusion pumps market statistics, including the chemotherapy infusion pumps industry global market size, regional shares, competitors with chemotherapy infusion pumps market share, detailed chemotherapy infusion pumps market segments, market trends, and opportunities, and any further data you may need to thrive in the chemotherapy infusion pumps industry. These chemotherapy infusion pumps market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The chemotherapy infusion pumps market consists of sales of portable elastomeric infusion pumps, electronic infusion pumps, implantable infusion pumps, and patient-controlled analgesia (PCA) pumps. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.